IL319899A - משטרי מינון של ריספרידון עם מערכות להשהייה בקיבה - Google Patents

משטרי מינון של ריספרידון עם מערכות להשהייה בקיבה

Info

Publication number
IL319899A
IL319899A IL319899A IL31989925A IL319899A IL 319899 A IL319899 A IL 319899A IL 319899 A IL319899 A IL 319899A IL 31989925 A IL31989925 A IL 31989925A IL 319899 A IL319899 A IL 319899A
Authority
IL
Israel
Prior art keywords
risperidone
salt
segment
period
gastric residence
Prior art date
Application number
IL319899A
Other languages
English (en)
Inventor
Richard Scranton
Nayana Nagaraj
Xuemin Jiang
Original Assignee
Lyndra Therapeutics Inc
Richard Scranton
Nayana Nagaraj
Xuemin Jiang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lyndra Therapeutics Inc, Richard Scranton, Nayana Nagaraj, Xuemin Jiang filed Critical Lyndra Therapeutics Inc
Publication of IL319899A publication Critical patent/IL319899A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL319899A 2022-09-30 2023-09-29 משטרי מינון של ריספרידון עם מערכות להשהייה בקיבה IL319899A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263377961P 2022-09-30 2022-09-30
PCT/US2023/075648 WO2024073752A2 (en) 2022-09-30 2023-09-29 Risperidone dosage regimens with gastric residence systems

Publications (1)

Publication Number Publication Date
IL319899A true IL319899A (he) 2025-05-01

Family

ID=90479181

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319899A IL319899A (he) 2022-09-30 2023-09-29 משטרי מינון של ריספרידון עם מערכות להשהייה בקיבה

Country Status (6)

Country Link
EP (1) EP4593929A2 (he)
JP (1) JP2025531626A (he)
CN (1) CN120303029A (he)
AU (1) AU2023354428A1 (he)
IL (1) IL319899A (he)
WO (1) WO2024073752A2 (he)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
IL286512B2 (he) 2019-03-20 2026-03-01 Lyndra Therapeutics Inc כמוסות וציפויי כמוסות לצורות מינון לשהייה בקיבה
CN113840596A (zh) 2019-03-20 2021-12-24 林德拉治疗公司 用于胃滞留剂型的衣层

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110052700A1 (en) * 2009-08-31 2011-03-03 Depomed, Inc. Gastric retentive pharmaceutical compositions for immediate and extended release of levosulpiride
MX2016016406A (es) * 2014-06-11 2017-10-12 Massachusetts Inst Technology Estructuras de permanencia, y métodos relacionados.
JP2024503485A (ja) * 2021-01-19 2024-01-25 リンドラ セラピューティクス， インコーポレイティド リスペリドンを投与するための胃内滞留システム
IL314378A (he) * 2022-01-19 2024-09-01 Lyndra Therapeutics Inc צורות מינון לשימור קיבה

Also Published As

Publication number Publication date
WO2024073752A2 (en) 2024-04-04
AU2023354428A1 (en) 2025-04-17
JP2025531626A (ja) 2025-09-22
WO2024073752A3 (en) 2024-05-30
EP4593929A2 (en) 2025-08-06
CN120303029A (zh) 2025-07-11

Similar Documents

Publication Publication Date Title
US20240390270A1 (en) Gastric residence systems for administration of risperidone
US20250339368A1 (en) Dosage forms for gastric retention
US20220387311A1 (en) Gastric residence systems for administration of active agents
EP4593929A2 (en) Risperidone dosage regimens with gastric residence systems
US20220409528A1 (en) Gastric residence systems having a filament for improved gastric residence
US20240252483A1 (en) Gastric residence systems comprising buprenorphine and naloxone
US20240335400A1 (en) Gastric residence systems comprising methadone
US20230190941A1 (en) Polymeric linkers for a gastric residence system
CN117083059A (zh) 用于利培酮施用的胃滞留系统
US20250295901A1 (en) Flexible line configurations for gastric residence systems
CN118871091A (zh) 用于胃滞留的剂型